<DOC>
	<DOCNO>NCT00304434</DOCNO>
	<brief_summary>Objective 1 : Determine safety toxicity profile Tamiflu administer combination probenecid healthy adults.Objective 2 : Determine pharmacokinetic profile Tamiflu probenecid healthy adult .</brief_summary>
	<brief_title>Evaluation Alternative Oseltamivir ( Tamiflu ) Dosing Strategies .</brief_title>
	<detailed_description>In vitro study determine 50 % inhibitory concentration ( IC50 ) Ro 64-0802 influenza neuraminidases range 0.3 22 nmol/L ( 0.08 - 0.28 g/L 0.08 -0.28 ng/mL ) . IC50 value influenza strain cell culture somewhat high variable range 0.6 155 nmol/L ( 0.17 - 32.8 g/L 0.17 - 32.8 ng/mL ) . Tamiflu also show vitro mouse challenge activity H5N1 virus . EC50 value H5N1 strain replication Madin Darby canine kidney ( MDCK ) cell range 7.5-12 M neuraminidase activity 7.0-15 nM ( IC50 value ) . The current U.S. FDA approve recommendation influenza A B treatment use oseltamivir suggest dose 75mg take orally twice daily 5 day onset symptom laboratory confirmation infection . Prophylaxis influenza A infection people expose high risk exposure suggest dose 75 mg orally take daily 6 week . No clinical trial human infect require prophylaxis H5N1 variant perform . Oseltamivir treatment human pediatric case H5N1 influenza pneumonia publish . Oseltamivir give late course illness child subsequently expire . Several people give prophylactic course oseltamivir avian influenza ( H7N7 , H7N3 ) outbreaks Netherlands British Columbia , appear effective prevent additional human case . Clinical trial use oseltamivir influenza treatment recently review . Two phase III placebo control , blind study perform adult , three geriatric population , one pediatric patient . In general , flu symptom decrease one day great patient receive Tamiflu compare placebo . Several prophylaxis study use oseltamivir conduct healthy unvaccinated adult also recently review . In several trial involve either prophylaxis household exposure exposure community demonstrate incidence influenza significantly reduce ( range 70-90 % ) patient receive Tamiflu , 75mg orally daily 42 day compare placebo . Side effect profile prophylaxis study indicate nausea vomit commonly find Tamiflu arm compare placebo . There difference side effect incidence young compare old adult ( &gt; 65 year ) population .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Oseltamivir</mesh_term>
	<mesh_term>Probenecid</mesh_term>
	<criteria>Subjects include male nonpregnant female 18 year old Subjects understand study potential safety concern sign inform consent form prior admission study Subjects willing complete require assessment , test evaluations able make study visit Hemoglobin &gt; 10.0 g/dL male &gt; 9.0 g/dL female ; b ) Platelet count &gt; 75,000 / L ; c ) Absolute neutrophil count &gt; 1000 / L ; SGOT SGPT &lt; 2.5 time normal upper limit ( UL ) ; Serum uric acid WNL ; Creatinine &lt; 1.5 time normal upper limit ( normal UL 1.5 mg/dL ) &lt; 65 year age group MUST WNL &gt; 65 year age group ; creatinine clearance &gt; 50 mL/min Subjects creatinine clearance &lt; 50 mL/min Subjects pregnant breast feeding female Subjects employ adequate contraception Subjects drug alcohol abuser opinion investigator would interfere subject compliance safety Subjects currently participate clinical research study Any acute serious infection require prescription therapy within 14 day prior Day 1 study Subjects may recently expose influenza Subjects gout , blood dyscrasia , history hypersensitivity sulfonamide drug Subjects contraindication study medication History allergic reaction probenecid Have kidney disease , kidney stone , poorly function kidney Have active peptic ulcer disease On high dose aspirin salicylate therapy Receiving follow medication ( relative contraindication probenecid ) : Acyclovir , allopurinol , penicillamine , clofibrate , rifampin , methotrexate , zidovudine , theophylline , dapsone , penicillins cephalosporin , nonsteroidal antiinflammatory drug ( NSAIDS ) ibuprofen ( Motrin , Advil , Nuprin , others ) , ketoprofen ( Orudis , Oruvail , Orudis KT ) , diclofenac ( Cataflam , Voltaren ) , etodolac ( Lodine ) , fenoprofen ( Nalfon ) , flurbiprofen ( Ansaid ) , indomethacin ( Indocin ) , ketorolac ( Toradol ) , nabumetone ( Relafen ) , oxaprozin ( Daypro ) , piroxicam ( Feldene ) , sulindac ( Clinoril ) , tolmetin ( Tolectin ) , naproxen ( Aleve , Anaprox , Naprosyn ) ; sulfabased medication sulfamethoxazole ( Bactrim , Septra , Gantanol ) , sulfasalazine ( Azulfidine ) , sulfinpyrazone ( Anturane ) , sulfisoxazole ( Gantrisin ) , others ; oral diabetes medicine glipizide ( Glucotrol ) , glyburide ( Micronase , Diabeta , Glynase ) , tolbutamide ( Orinase ) , tolazamide ( Tolinase ) ; barbiturate phenobarbital ( Luminal , Solfoton ) , amobarbital ( Amytal ) , secobarbital ( Seconal ) , others ; benzodiazepine ( use treat anxiety panic disorder induce sleep ) alprazolam ( Xanax ) , diazepam ( Valium ) , lorazepam ( Ativan ) , temazepam ( Restoril ) , chlordiazepoxide ( Librium ) , clonazepam ( Klonopin ) , clorazepate ( Tranxene ) , oxazepam ( Serax ) , estazolam ( ProSom ) , flurazepam ( Dalmane ) , quazepam ( Doral ) , triazolam ( Halcion ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Adverse effect</keyword>
	<keyword>Antiviral</keyword>
	<keyword>Clinical trial</keyword>
	<keyword>Oseltamivir</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Probenecid</keyword>
</DOC>